Showing results (1-10 of 84) with videos related to
Sort By:
Pageof 9
Advances in Cancer Research|November 3, 2009
Chapter 5: Nuclear CLU (nCLU) and the fate of the cellSaverio Bettuzzi, Federica RizziAdvances in Cancer Research|November 3, 2009
Clusterin (CLU) and prostate cancerFederica Rizzi, Saverio BettuzziEndocrine-Related Cancer|November 12, 2009
The clusterin paradigm in prostate and breast carcinogenesisFederica Rizzi, Saverio BettuzziSpringerplus|November 9, 2016
Family-school relationship in the Italian infant schools: not only a matter of cultural diversityAnna Granata, Ouejdane Mejri, Federica RizziAdvances in Cancer Research|November 3, 2009
Chapter 2: Clusterin (CLU): From one gene and two transcripts to many proteinsFederica Rizzi, Mariangela Coletta, Saverio BettuzziNutrients|December 20, 2018
Molecular Targets of Epigallocatechin-Gallate (EGCG): A Special Focus on Signal Transduction and CancerAide Negri, Valeria Naponelli, Federica Rizzi, et al.Journal of Cellular Physiology|January 13, 2009
Clusterin is a short half-life, poly-ubiquitinated protein, which controls the fate of prostate cancer cellsFederica Rizzi, Alessandro Emanuele Caccamo, Lucia Belloni, et al.Cancers|June 12, 2026
Integrating Extracellular Matrix Dynamics and Membrane-Associated Signaling: The Role of Clusterin-LRP1 Network in Cancer Cell Migration and Tumor ProgressionAlessia Ciringione, Federica Rizzi, Sylvia Mangani, et al.Antioxidants (Basel, Switzerland)|April 6, 2017
Green Tea Catechins for Prostate Cancer Prevention: Present Achievements and Future ChallengesValeria Naponelli, Ileana Ramazzina, Chiara Lenzi, et al.Cancer Research|January 21, 2006
Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: a preliminary report from a one-year proof-of-principle studySaverio Bettuzzi, Maurizio Brausi, Federica Rizzi, et al.Pageof 9